IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
India · Delayed Price · Currency is INR 169.55
+5.75 (3.51%)
At close: Aug 21, 2026
BOM:524164 Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 25,236 | 23,191 | 20,792 | 21,328 | 22,171 | 21,840 |
Revenue Growth | 18.56% | 11.54% | -2.51% | -3.80% | 1.52% | 11.03% |
Gross Profit Gross Profit Growth | 8,931 | 8,023 | 6,621 | 7,143 | 6,566 | 6,028 |
Operating Income Operating Income Growth | 2,293 | 1,895 | 1,305 | 1,677 | 1,801 | 2,161 |
Net Income Net Income Growth | 1,681 | 1,376 | 1,011 | 1,344 | 1,391 | 1,677 |
Earnings Per Share EPS Growth | 5.73 | 4.69 | 3.44 | 4.58 | 4.74 | 5.71 |
EPS Growth | 59.99% | 36.31% | -24.89% | -3.38% | -17.02% | -62.52% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Pharmaceutical Growth | 15,364 | 13,963 | 12,123 | 12,625 | 12,585 | 10,027 |
Chemical Chemical Growth | 12,444 | 11,605 | 10,794 | 11,402 | 11,949 | 13,183 |
Unallocated Unallocated Growth | 221.9 | 213.8 | 224.3 | 58 | 48.7 | 64.9 |
Inter Segment Inter Segment Growth | -2,572 | -2,377 | -2,125 | -2,758 | -2,411 | -1,434 |
Total Total Growth | 25,458 | 23,404 | 21,016 | 21,328 | 22,171 | 21,840 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,003 | 2,003 | 2,093 | 1,428 | 186.4 | 1,197 |
Total Debt Total Debt Growth | 1,354 | 1,354 | 1,170 | 327.6 | 798.1 | 439.5 |
Net Cash (Debt) Net Cash Growth | 648.8 | 648.8 | 922.5 | 1,100 | -611.7 | 757.8 |
Net Cash Growth | -29.67% | -29.67% | -16.14% | - | - | -77.30% |
Net Cash Per Share Net Cash Per Share Growth | 2.21 | 2.21 | 3.14 | 3.75 | -2.08 | 2.58 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,143 | 1,786 | 2,898 | 1,223 | 930.5 |
Capital Expenditures CapEx Growth | - | -1,730 | -2,136 | -2,742 | -2,118 | -1,533 |
Free Cash Flow Free Cash Flow Growth | - | 413.3 | -349.3 | 156.1 | -895.5 | -602.4 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 35.39% | 34.59% | 31.84% | 33.49% | 29.61% | 27.60% |
Operating Margin | 9.09% | 8.17% | 6.28% | 7.86% | 8.12% | 9.90% |
Pretax Margin | 8.94% | 7.95% | 6.64% | 8.52% | 8.51% | 10.30% |
Profit Margin | 6.66% | 5.93% | 4.86% | 6.30% | 6.28% | 7.68% |
FCF Margin | - | 1.78% | -1.68% | 0.73% | -4.04% | -2.76% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.800 | 1.000 | 0.800 | 0.800 |
Dividend Per Share Growth | 25.00% | 25.00% | -20.00% | 25.00% | 0% | -33.33% |
Dividend Yield | 0.59% | 1.38% | 1.32% | 1.42% | 1.47% | 1.19% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.61 | 15.51 | 17.77 | 15.79 | 11.94 | 12.39 |
Forward PE | 21.06 | 14.55 | 10.75 | 9.60 | 10.45 | - |
P/FCF Ratio | 120.42 | 51.67 | - | 135.95 | - | - |
PS Ratio | 1.97 | 0.92 | 0.86 | 1.00 | 0.75 | 0.95 |